September 8, 2025: FDA launches an import alert listing safe GLP 1 manufacturers Partnership for Safe Medicines FDA Compliance for Peptide Therapy and BPC 157 Holt Law FDA's Overreach on Compounded Peptides Supplement Marketer Welcomes Friendlier Regime Under RFK Jr. 12 19 2024 The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York